Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains

Journal of Psychiatric Research

Volumn 43, Issue 14, 2009, Pages 1175-1184

  Dunham, J S ^a   Deakin, J F W ^a   Miyajima, F ^a   Payton, A ^a   Toro, C T ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CRANFIELD UNIVERSITY   (United Kingdom)

Author keywords

Expression; Mood disorders; Neurotrophin; Polymorphism; Postmortem; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DNA; LITHIUM SALT; NEUROLEPTIC AGENT; PROTEIN P75;

ADULT; ARTICLE; AUTORADIOGRAPHY; BIPOLAR DISORDER; BRAIN ASYMMETRY; CONTROLLED STUDY; DENTATE GYRUS; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEMISPHERIC DOMINANCE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOAUTORADIOGRAPHY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE FIXATION;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; GENOTYPE; HIPPOCAMPUS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMORTEM CHANGES; RADIOIMMUNOTHERAPY; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKB; SCHIZOPHRENIA;

EID: 70149088982     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.03.008     Document Type: Article

References (60)

1. Adams J.H., Wigg K.G., King N., Burcescu I., Vetro A., Kiss E., et al. Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders. Ameican Journal of Medical Genetics B and Neuropsychiatric Genetics 132 (2005) 90-95
2. Allen S.J., Dawbarn D., Eckford S.D., Wilcock G.K., Ashcroft M., Colebrook S.M., et al. Cloning of a non-catalytic form of human trkB and distribution of messenger RNA for trkB in human brain. Neuroscience 60 (1994) 825-834
3. Angelucci F., Brene S., and Mathe A.A. BDNF in schizophrenia, depression and corresponding animal models. Molecular Psychiatry 10 (2005) 345-352
4. Ashe P.C., Chlan-Fourney J., Juorio A.V., and Li X.M. Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus. Brain Research 956 (2002) 126-135
5. Bai O., Chlan-Fourney J., Bowen R., Keegan D., and Li X.M. Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. Journal of Neuroscience Research 71 (2003) 127-131
6. Bai O., Wei Z., Lu W., Bowen R., Keegan D., and Li X.M. Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal. Journal of Neuroscience Research 69 (2002) 278-283
7. Baxter G.T., Radeke M.J., Kuo R.C., Makrides V., Hinkle B., Hoang R., et al. Signal transduction mediated by the truncated trkB receptor isoforms, trkB.T1 and trkB.T2. Journal of Neuroscience 17 (1997) 2683-2690
8. Biffo S., Offenhauser N., Carter B.D., and Barde Y.A. Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development. Development 121 (1995) 2461-2470
9. Brouha A.K.W.C., Hyde T.M., Hennan M.M., Murray A.M., Bigelow L.B., Weinberger D.R., et al. Reductions in brain-derived neurotrophic factor mRNA in the hippocampus of patients with schizophrenia. Society of Neuroscience Abstract (1996) 1680
10. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 50 (2001) 260-265
11. Chlan-Fourney J., Ashe P., Nylen K., Juorio A.V., and Li X.M. Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Research 954 (2002) 11-20
12. Chuang D.M. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Annals of the New York Academy of Science 1053 (2005) 195-204
13. Connor B., Young D., Lawlor P., Gai W., Waldvogel H., Faull R.L., et al. Trk receptor alterations in Alzheimer's disease. Brain Research Molecular Brain Research 42 (1996) 1-17
14. Costafreda SG, Brammer MJ, David AS, Fu CH. Predictors of amygdala activation during the processing of emotional stimuli: A meta-analysis of 385 PET and fMRI studies. Brain Reserach Review; 2007 [Nov epub].
15. Dechant G., and Barde Y.A. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nature Neuroscience 5 (2002) 1131-1136
16. Del-Ben C.M., Deakin J.F., McKie S., Delvai N.A., Williams S.R., Elliott R., et al. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 30 (2005) 1724-1734
17. Djalali S., Holtje M., Grosse G., Rothe T., Stroh T., Grosse J., et al. Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. Journal of Neurochemistry 92 (2005) 616-627
18. Dowlatshahi D., MacQueen G.M., Wang J.F., Reiach J.S., and Young L.T. G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. Journal of Neurochemistry 73 (1999) 1121-1126
19. Durany N., Michel T., Zochling R., Boissl K.W., Cruz-Sanchez F.F., Riederer P., et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophrenia Research 52 (2001) 79-86
20. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
21. Eide F.F., Vining E.R., Eide B.L., Zang K., Wang X.Y., and Reichardt L.F. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. Journal of Neuroscience 16 (1996) 3123-3129
22. Freeman B., Smith N., Curtis C., Huckett L., Mill J., and Craig I.W. DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behaviour Genetics 33 (2003) 67-72
23. Guillin O., Griffon N., Diaz J., Le Foll B., Bezard E., Gross C., et al. Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. International Review of Neurobiology 59 (2004) 425-444
24. Haga H., Yamada R., Ohnishi Y., Nakamura Y., and Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190, 562 genetic variations in the human genome. Single-nucleotide polymorphism. Journal of Human Genetics 47 (2002) 605-610
25. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122 (1999) 593-624
26. Harrison P.J. The neuropathology of primary mood disorder. Brain 125 (2002) 1428-1449
27. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174 (2004) 151-162
28. Hashimoto K., Shimizu E., and Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Research and Brain Research Review 45 (2004) 104-114
29. Heckers S., and Konradi C. Hippocampal neurons in schizophrenia. Journal of Neural Transmission 109 (2002) 891-905
30. Huang E.J., and Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annual Review of Neuroscience 24 (2001) 677-736
31. Iritani S., Niizato K., Nawa H., Ikeda K., and Emson P.C. Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Progress in Neuropsychopharmacology and Bioliogical Psychiatry 27 (2003) 801-807
32. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., and Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley neuropathology consortium. Molecular Psychiatry 9 (2004) 609-620 544
33. Kunugi H., Hashimoto R., Yoshida M., Tatsumi M., and Kamijima K. A missense polymorphism (S205L) of the low-affinity neurotrophin receptor p75NTR gene is associated with depressive disorder and attempted suicide. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 129 (2004) 44-46
34. Lessmann V. Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS. Genetic Pharmacology 31 (1998) 667-674
35. Levinson D.F. The genetics of depression: a review. Biological Psychiatry 60 (2006) 84-92
36. Lewin G.R., and Barde Y.A. Physiology of the neurotrophins. Annual Review of Neuroscience 19 (1996) 289-317
37. Li X.M., Chlan-Fourney J., Juorio A.V., Bennett V.L., Shrikhande S., Keegan D.L., et al. Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor. Journal of Neuroscience Research 56 (1999) 72-75
38. Lipska B.K., Khaing Z.Z., Weickert C.S., and Weinberger D.R. BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. European Journal of Neuroscience 14 (2001) 135-144
39. Miyajima F., Ollier W., Mayes A., Jackson A., Thacker N., Rabbitt P., et al. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes, Brain and Behaviour 7 4 (2008) 411-417
40. Nelson M.D., Saykin A.J., Flashman L.A., and Riordan H.J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Archives of General Psychiatry 55 (1998) 433-440
41. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Molecular Psychiatry 10 (2005) 208-212
42. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., and Kennedy J.L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. American Journal of Human Genetics 71 (2002) 651-655
43. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 15 (1995) 7539-7547
44. Norbury R., Mackay C.E., Cowen P.J., Goodwin G.M., and Harmer C.J. Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. British Journal of Psychiatry 190 (2007) 531-532
45. Ozbas-Gerceker F., Gorter J.A., Redeker S., Ramkema M., van der Valk P., Baayen J.C., et al. Neurotrophin receptor immunoreactivity in the hippocampus of patients with mesial temporal lobe epilepsy. Neuropathology and Applied Neurobiology 30 (2004) 651-664
46. Romanczyk T.B., Weickert C.S., Webster M.J., Herman M.M., Akil M., and Kleinman J.E. Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan. European Journal of Neuroscience 15 (2002) 269-280
47. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. Journal of Neuroscience 23 (2003) 349-357
48. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lim Y.M., Tsan G., et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Molecular Psychiatry 7 (2002) 579-593
49. Spires T.L., Grote H.E., Varshney N.K., Cordery P.M., van Dellen A., Blakemore C., et al. Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. Journal of Neurosci 24 (2004) 2270-2276
50. Strauss J., Barr C.L., George C.J., King N., Shaikh S., Devlin B., et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 131 (2004) 16-19
51. Szekeres G., Juhasz A., Rimanoczy A., Keri S., and Janka Z. The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia. Schizophrenia Research 65 (2003) 15-18
52. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., et al. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Molecular Psychiatry 5 (2000) 293-300
53. Thome J., Foley P., and Riederer P. Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article. Journal of Neural Transmission 105 (1998) 85-100
54. Toro C.T., and Deakin J.F.W. NMDA receptor subunit NR1 and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophrenia Research 80 (2005) 323-330
55. Videbech P., and Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry 161 (2004) 1957-1966
56. Webster M.J., Herman M.M., Kleinman J.E., and Shannon Weickert C. BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expression Patterns 6 (2006) 941-951
57. Webster M.J., Weickert C.S., Herman M.M., and Kleinman J.E. BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Research Development and Brain Research 139 (2002) 139-150
58. Webster MJ, Kleinman, JE, Weickert, CS. BDNF and TrkBTK + mRNA Levels in the Prefrontal Cortex and Hippocampus of Individuals with Depression. Bipolar Disorder and Schizophrenia; 2004 [personal communication].
59. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., and Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry 157 (2000) 16-25
60. Yang J., Siao C.J., Nagappan G., Marinic T., Jing D., McGrath K., et al. Neuronal release of proBDNF. Nature Neuroscience 12 (2009) 113-115